Atossa Therapeutics Newsroom

H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 13 01:31

Atossa Therapeutics Analyst Ratings

BenzingaDec 13 01:26

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsDec 12 21:31

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsDec 12 04:31

Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow JonesDec 9 18:02

Atossa Therapeutics Analyst Ratings

BenzingaDec 9 17:52

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 14 03:32

H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Raises Target Price to $7

Futu NewsNov 13 19:31

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 7 01:32

Atossa Therapeutics Analyst Ratings

BenzingaNov 5 22:32

H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 4 23:31

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 2 03:31

H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $6

Futu NewsOct 31 22:31

Atossa Therapeutics Analyst Ratings

BenzingaSep 11 17:47

Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $6.5

BenzingaSep 11 17:47

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $4

Futu NewsAug 14 01:31

HC Wainwright & Co. Reiterates Buy on Atossa Therapeutics, Maintains $6 Price Target

BenzingaAug 13 01:54

HC Wainwright & Co. Reiterates Buy on Atossa Therapeutics, Maintains $6 Price Target

BenzingaJun 28 23:13

Atossa Therapeutics Analyst Ratings

BenzingaJun 28 23:12

Atossa Therapeutics Analyst Ratings

BenzingaJun 21 01:27